Information for Brain Tumor Patients

New Brain Stem Cell | The Scientist Magazine®

Brain Tumor Neurosurgeons

Karin Muraszko, M.D
Chair and Julian T Hoff M.D. Professor, Neurosurgery
Professor, Neurological Surgery
Professor, Dept of Pediatrics and Comm Diseases
Professor of Plastic Surgery, Dept of Surgery
karinm@med.umich.edu
734-615-0536
http://medicine.umich.edu/dept/neurosurgery/karin-muraszko-md

Oren Sagher, M.D.
Professor of Neurosurgery
Professor of Anesthesiology
osagher@med.umich.edu
734-936-9593
http://medicine.umich.edu/dept/neurosurgery/oren-sagher-md

Jason Heth, M.D.
Clinical Assistant Professor, Neurosurgery
jhethg@med.umich.edu
734-936-9593
http://medicine.umich.edu/dept/neurosurgery/jason-anthony-heth-md

Shawn Hervey-Jumper, M.D.

Assistant Professor, Neurosurgery

herveyju@umich.edu

734-647-7960
https://medicine.umich.edu/dept/neurosurgery/shawn-hervey-jumper-md


Daniel A. Orringer, M.D.

Assistant Professor, Neurosurgery

dorringe@med.umich.edu
734-647-9222
https://medicine.umich.edu/dept/neurosurgery/daniel-orringer-md



Principal Investigators

Maria G. Castro, Ph.D. and Pedro R. Lowenstein, M.D., Ph.D


Clinical Trial:  

“A non-randomized, open-label dose-finding trial of combined cytotoxic and immunestimulatory strategy for the treatment of primary GBM, utilizing adenovirus vector type 5 (Ad-hCMV-TK) expressing herpes simplex virus thymidine kinase, and Ad vector type 5 (Ad-hCMV-Flt3L) expressing fms-like tyrosine kinase ligand” currently ongoing at our institution (IND number BB14574, clinicaltrials.gov number NCT01811992).

http://clinicaltrials.gov/ct2/results?term=Lowenstein+AND+glioma&Search=Search



Neuro-oncologists

Larry Junck, M.D.
Professor of Neurology
ljunch@umich.edu
734-936-7910
http://www.med.umich.edu/neurology/faculty/junck_research_bio.htm

Aaron Mammoser, M.D.
Assistant Professor of Neurology
amammose@umich.edu
734/936-7910
http://www.uofmhealth.org/profile/2525/aaron-gerald-mammoser-md


Useful Links

Comments